Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS · Delayed Price · Currency is USD
0.1002
+0.0002 (0.15%)
Mar 28, 2025, 3:57 PM EST

PVCT Revenue

In the year 2024, Provectus Biopharmaceuticals had annual revenue of $617.14K with 10.66% growth. Provectus Biopharmaceuticals had revenue of $14.33K in the quarter ending December 31, 2024, a decrease of -88.17%.

Revenue
617.14K
Revenue Growth
+10.66%
P/S Ratio
68.13
Revenue / Employee
154.29K
Employees
4
Market Cap
43.87M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024617.14K59.43K10.66%
Dec 31, 2023557.71K-431.33K-43.61%
Dec 31, 2022989.04K--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition